Lissa, on RealMoney.com, recently worried about BTK 300, now ready to rumble. Bossman approves.
Lissa Morgenthaler biotech
6/15/01 11:04 AM ET Well, we bought everything in sight this morning: HGSI, PDLI, GENZ, ABGX, MEDX and more. May have been too soon but biotech is short-term oversold and due for a bounce. Spent much of the past few weeks dancing with the elephants and now finishing an article to be posted later today on what the elephants think.
...
Jim Cramer Lissa
6/15/01 11:09 AM ET Lissa, thanks for those names!! That's what we want. Great job and it looks like a great call!!!!
...
Lissa Morgenthaler cancer stocks
6/15/01 3:37 PM ET I'm looking forward to Monday morning on CNBC. (7 A.M. on the East Coast and - gaak! - 4 A.M. for us West-Coasters.) CNBC will focus on cancer stocks, which should be fun and may be lifting the stocks today. We own several including AGEN, CELG, ENMD, IMCL, IMGN, and OSIP. I don't know which ones CNBC will dub the winners but I'm anticipating the spectacle the way you guys slobber over the Sixers. |